Evidence map›Paper›PMID 42606525›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2026

Adverse Effects of Carbon Black Nanoparticles on Maternal and Fetal Lungs in Pregnant Mice: Insights From a Metabolomics Perspective.

Jing Li, Biling Gao, Hao Chang, Jingjing Zhan, Zhonghua Lu, Zehua Xu, Yi Lin, Jia Li, Heqing Shen

Abstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jing LiDepartment of Preventive Medicine, School of Public Health, Fujian Medical University, Fuzhou, China.
Biling GaoState Key Laboratory of Vaccines for Infectious Diseases, Xiang an Biomedicine Laboratory & State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen, People's Republic of China.
Hao ChangState Key Laboratory of Vaccines for Infectious Diseases, Xiang an Biomedicine Laboratory & State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen, People's Republic of China.
Jingjing ZhanXiamen Meliomics Technology Co., Ltd., Xiamen, People's Republic of China.
Zhonghua LuState Key Laboratory of Vaccines for Infectious Diseases, Xiang an Biomedicine Laboratory & State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen, People's Republic of China.
Zehua XuState Key Laboratory of Vaccines for Infectious Diseases, Xiang an Biomedicine Laboratory & State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen, People's Republic of China.
Yi LinState Key Laboratory of Vaccines for Infectious Diseases, Xiang an Biomedicine Laboratory & State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen, People's Republic of China.
Jia LiXiamen Meliomics Technology Co., Ltd., Xiamen, People's Republic of China.
Heqing ShenState Key Laboratory of Vaccines for Infectious Diseases, Xiang an Biomedicine Laboratory & State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen, People's Republic of China.ORCID https://orcid.org/0000-0002-6544-4919

Funding

MOST | National Natural Science Foundation of China (NSFC) 22076158MOST | National Natural Science Foundation of China (NSFC) 22576173MOST | National Natural Science Foundation of China (NSFC) 91543113| Natural Science Foundation of Fujian Province (Fujian Natural Science Foundation) 2025J01762Start-up funding for high-level talent research of Fujian Medical University XRCZX2024028
6 · The paper itself

Abstract

Previous studies have linked prenatal exposure to carbon black nanoparticles (CBNPs), a key constituent of air pollution and tobacco smoke, to respiratory abnormalities. However, the distinct impacts of particle size on the maternal-fetal lung axis remain poorly understood. This study investigated the maternal-to-fetal lung toxicological effects and metabolic shifts following exposure to 30 nm (CBNP30) and 120 nm (CBNP120) particles using a high-dose mechanistic exposure model. In maternal lungs, histological analysis (H&E and Masson staining) revealed severe inflammatory infiltration and significant fibrotic injury for both sizes, with CBNP120 inducing more pronounced damage. Dark-field hyperspectral imaging confirmed the transplacental transfer and presence of both CBNP sizes within fetal lung tissues. Notably, fetal lungs did not display overt histological injury. However, significant elevations in oxidative stress and inflammatory markers (mRNA and protein) were observed, indicating clear molecular perturbation. Chemical Isotope Labeling LC-MS further identified size-specific metabolic disruption, with CBNP120 eliciting more extensive changes in the fetal metabolome. Specifically, CBNP30 primarily affected histidine metabolism in both maternal and fetal lungs, whereas CBNP120 disrupted butanoate and arachidonic acid pathways. These metabolic shifts, supported by altered enzyme expression, suggest that profound biochemical disturbances may occur in the fetus even in the absence of observable morphological damage. This study clarifies the distinction between maternal structural injury and fetal molecular dysfunction, providing critical insights for interventions against air pollution-related neonatal health risks.

Indexed as

FetusLungMetabolomicsNanoparticlesSootAnimalsFemaleMaternal ExposureMiceOxidative StressPregnancySootadverse effectCBNPslung injurymetabolomicsprenatal exposure

Identifiers

PMID42606525
PMCPMC13480342

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.